Logo image of CELL.CA

GRID BATTERY METALS INC (CELL.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:CELL - CA3980841033 - Common Stock

0.03 CAD
0 (0%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

2

Overall CELL gets a fundamental rating of 2 out of 10. We evaluated CELL against 814 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for CELL as it has an excellent financial health rating, but there are worries on the profitability. CELL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CELL had negative earnings in the past year.
CELL had a negative operating cash flow in the past year.
CELL had negative earnings in 4 of the past 5 years.
In the past 5 years CELL always reported negative operating cash flow.
CELL.CA Yearly Net Income VS EBIT VS OCF VS FCFCELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M

1.2 Ratios

CELL has a worse Return On Assets (-83.93%) than 72.73% of its industry peers.
CELL has a worse Return On Equity (-84.78%) than 63.76% of its industry peers.
Industry RankSector Rank
ROA -83.93%
ROE -84.78%
ROIC N/A
ROA(3y)-29.33%
ROA(5y)-62.54%
ROE(3y)-29.86%
ROE(5y)-63.39%
ROIC(3y)N/A
ROIC(5y)N/A
CELL.CA Yearly ROA, ROE, ROICCELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K -1K

1.3 Margins

CELL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CELL.CA Yearly Profit, Operating, Gross MarginsCELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, CELL has more shares outstanding
Compared to 5 years ago, CELL has more shares outstanding
Compared to 1 year ago, CELL has an improved debt to assets ratio.
CELL.CA Yearly Shares OutstandingCELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CELL.CA Yearly Total Debt VS Total AssetsCELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 77.44 indicates that CELL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 77.44, CELL belongs to the best of the industry, outperforming 88.08% of the companies in the same industry.
CELL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 77.44
ROIC/WACCN/A
WACCN/A
CELL.CA Yearly LT Debt VS Equity VS FCFCELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

A Current Ratio of 24.37 indicates that CELL has no problem at all paying its short term obligations.
The Current ratio of CELL (24.37) is better than 93.49% of its industry peers.
CELL has a Quick Ratio of 24.37. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
CELL has a better Quick ratio (24.37) than 93.49% of its industry peers.
Industry RankSector Rank
Current Ratio 24.37
Quick Ratio 24.37
CELL.CA Yearly Current Assets VS Current LiabilitesCELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

CELL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.66%.
EPS 1Y (TTM)4.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CELL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELL.CA Price Earnings VS Forward Price EarningsCELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELL.CA Per share dataCELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CELL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

GRID BATTERY METALS INC

TSX-V:CELL (12/24/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-28 2025-11-28
Earnings (Next)02-19 2026-02-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.63%
Ins Owner ChangeN/A
Market Cap5.80M
Revenue(TTM)N/A
Net Income(TTM)-3.48M
Analysts80
Price Target0.19 (533.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -83.93%
ROE -84.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.33%
ROA(5y)-62.54%
ROE(3y)-29.86%
ROE(5y)-63.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6216.04%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.37
Quick Ratio 24.37
Altman-Z 77.44
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5571.27%
Cap/Depr(5y)4362.76%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-97.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-194.71%
OCF growth 3YN/A
OCF growth 5YN/A

GRID BATTERY METALS INC / CELL.CA FAQ

What is the ChartMill fundamental rating of GRID BATTERY METALS INC (CELL.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CELL.CA.


What is the valuation status of GRID BATTERY METALS INC (CELL.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to GRID BATTERY METALS INC (CELL.CA). This can be considered as Overvalued.


What is the profitability of CELL stock?

GRID BATTERY METALS INC (CELL.CA) has a profitability rating of 0 / 10.


How financially healthy is GRID BATTERY METALS INC?

The financial health rating of GRID BATTERY METALS INC (CELL.CA) is 8 / 10.